Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma-Reference-Cited by-同舟云学术

Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma

Published:2010-05-12 Issue:8 Volume:101 Page:1913-1919
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Hasita Horlad,Komohara Yoshihiro,Okabe Hirohisa,Masuda Toshiro,Ohnishi Koji,Lei Xiao F.,Beppu Toru,Baba Hideo,Takeya Motohiro

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2010.01614.x/fullpdf

Reference40 articles.

1. Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities;Shirabe;Surgery,2002

2. Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis;Shirabe;Am J Surg,2004

3. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multi-variate analysis;Hanazaki;Hepatogastroenterology,2002

4. Comparative clinico-pathological study of resected intrahepatic cholangiocarcinoma in northeast Thailand and Japan;Suzuki;J Hepatobiliary Pancreat Surg,2000

5. Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan;Isaji;J Hepatobiliary Pancreat Surg,1999

Cited by 227 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-33/ST2 Signaling and its Correlation with Macrophage Heterogeneity and Clinicopathologic Features in Human Intrahepatic Cholangiocarcinoma;Current Cancer Drug Targets;2024-11

2. Tumor-associated macrophages: orchestrators of cholangiocarcinoma progression;Frontiers in Immunology;2024-09-03

3. Unveil Intrahepatic Cholangiocarcinoma Heterogeneity through the Lens of Omics and Multi-Omics Approaches;Cancers;2024-08-20

4. Multi-Omics Classification of Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis;Cancers;2024-07-20

5. Detailed role of SR-A1 and SR-E3 in tumor biology, progression, and therapy;Cell Biochemistry and Biophysics;2024-06-17